|
1
|
Palumbo A and Anderson K: Multiple
myeloma. N Engl J Med. 364:1046–1060. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hideshima T, Mitsiades C, Tonon G,
Richardson PG and Anderson KC: Understanding multiple myeloma
pathogenesis in the bone marrow to identify new therapeutic
targets. Nat Rev Cancer. 7:585–598. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roodman GD: Pathogenesis of myeloma bone
disease. Leukemia. 23:435–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qiang YW, Chen Y, Brown N, Hu B, Epstein
J, Barlogie B and Shaughnessy JD Jr: Characterization of
Wnt/beta-catenin signalling in osteoclasts in multiple myeloma. Br
J Haematol. 148:726–738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Houben A, Kostanova-Poliakova D,
Weissenböck M, Graf J, Teufel S, von der Mark K and Hartmann C:
β-catenin activity in late hypertrophic chondrocytes locally
orchestrates osteoblastogenesis and osteoclastogenesis.
Development. Sep 12–2016.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morin PJ: Beta-catenin signaling and
cancer. Bioessays. 21:1021–1030. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhan T, Rindtorff N and Boutros M: Wnt
signaling in cancer. Oncogene. Sep 12–2016.(Epub ahead of print).
View Article : Google Scholar
|
|
8
|
Zhang B, Abreu JG, Zhou K, Chen Y, Hu Y,
Zhou T, He X and Ma JX: Blocking the Wnt pathway, a unifying
mechanism for an angiogenic inhibitor in the serine proteinase
inhibitor family. Proc Natl Acad Sci USA. 107:6900–6905. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Macdonald BT, Semenov MV and He X:
SnapShot: Wnt/beta-catenin signaling. Cell. 131:12042007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi W, Yang C, Dai Z, Che D, Feng J, Mao Y,
Cheng R, Wang Z, He X, Zhou T, et al: High levels of pigment
epithelium-derived factor in diabetes impair wound healing through
suppression of wnt signaling. Diabetes. 64:1407–1419. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sukhdeo K, Mani M, Zhang Y, Dutta J, Yasui
H, Rooney MD, Carrasco DE, Zheng M, He H, Tai YT, et al: Targeting
the beta-catenin/TCF transcriptional complex in the treatment of
multiple myeloma. Proc Natl Acad Sci USA. 104:7516–7521. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fulciniti M, Tassone P, Hideshima T,
Vallet S, Nanjappa P, Ettenberg SA, Shen Z, Patel N, Tai YT,
Chauhan D, et al: Anti-DKK1 mAb (BHQ880) as a potential therapeutic
Agent for multiple myeloma. Blood. 114:371–379. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsujimoto Y and Shimizu S: Another way to
die: Autophagic programmed cell death. Cell Death Differ. 12:(Supp
2). S1528–S1534. 2005. View Article : Google Scholar
|
|
14
|
Bursch W, Ellinger A, Gerner C, Frohwein U
and Schulte-Hermann R: Programmed cell death (PCD). apoptosis,
autophagic PCD, or others? Ann N Y Acad Sci. 926:1–12. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S, Guttridge DC, You Z, Zhang Z,
Fribley A, Mayo MW, Kitajewski J and Wang CY: Wnt-1 signaling
inhibits apoptosis by activating beta-catenin/T cell
factor-mediated transcription. J Cell Biol. 152:87–96. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hseu YC, Thiyagarajan V, Tsou HT, Lin KY,
Chen HJ, Lin CM, Liao JW and Yang HL: In vitro and in vivo
anti-tumor activity of CoQ0 against melanoma cells: inhibition of
metastasis and induction of cell-cycle arrest and apoptosis through
modulation of Wnt/β-catenin signaling pathways. Oncotarget.
7:22409–22426. 2016.PubMed/NCBI
|
|
17
|
Puissant A, Robert G and Auberger P:
Targeting autophagy to fight hematopoietic malignancies. Cell
Cycle. 9:3470–3478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T,
Fu W, Zhang J, Wu W, Zhang X and Chen YG: Autophagy negatively
regulates Wnt signalling by promoting dishevelled degradation. Nat
Cell Biol. 12:781–790. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang HW, Lee YS, Nam HY, Han MW, Kim HJ,
Moon SY, Jeon H, Park JJ, Carey TE, Chang SE, et al: Knockdown of
beta-catenin controls both apoptotic and autophagic cell death
through LKB1/AMPK signaling in head and neck squamous cell
carcinoma cell lines. Cell Signal. 25:839–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ashihara E, Kawata E, Nakagawa Y,
Shimazaski C, Kuroda J, Taniguchi K, Uchiyama H, Tanaka R, Yokota
A, Takeuchi M, et al: Beta-catenin small interfering RNA
successfully suppressed progression of multiple myeloma in a mouse
model. Clin Cancer Res. 15:2731–2738. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moon RT, Kohn AD, De Ferrari GV and Kaykas
A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev
Genet. 5:691–701. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Derksen PW, Tjin E, Meijer HP, Klok MD,
MacGillavry HD, van Oers MH, Lokhorst HM, Bloem AC, Clevers H,
Nusse R, et al: Illegitimate WNT signaling promotes proliferation
of multiple myeloma cells. Proc Natl Acad Sci USA. 101:6122–6127.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takada K, Zhu D, Bird GH, Sukhdeo K, Zhao
JJ, Mani M, Lemieux M, Carrasco DE, Ryan J, Horst D, et al:
Targeted disruption of the BCL9/β-catenin complex inhibits
oncogenic Wnt signaling. Sci Transl Med. 4:148ra1172012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sukhdeo K, Mani M, Hideshima T, Takada K,
Pena-Cruz V, Mendez G, Ito S, Anderson KC and Carrasco DR:
Beta-catenin is dynamically stored and cleared in multiple myeloma
by the proteasome-aggresome-autophagosome-lysosome pathway.
Leukemia. 26:1116–1119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung CH, Ro SH, Cao J, Otto NM and Kim DH:
mTOR regulation of autophagy. FEBS Lett. 584:1287–1295. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ming M, Wang S, Wu W, Senyuk V, Le Beau
MM, Nucifora G and Qian Z: Activation of Wnt/beta-catenin protein
signaling induces mitochondria-mediated apoptosis in hematopoietic
progenitor cells. J Biol Chem. 287:22683–22690. 2012. View Article : Google Scholar : PubMed/NCBI
|
